16
Jun
2026

Rivocean Hubei Pharmaceutical Co., Ltd.

Exhibitor at CPHI & PMEC China 2026 stand W1D36, Pharma Ingredients
About Us

Rivocean Pharm initially established in1992, is a Hi-tech company integrated with sales, R&D and production of fine chemicals and APIs. Rivocean pays much attention to Bio-medicine industry, its products including human & veterinary drugs. According to usage, products can be divided into Digestive System Drugs, Antibiotics, Cardiovascular Drugs, and Central Nervous Drugs. Mainly, Rivocean is engaged in APIs and intermediates of Pantoprazole, Phenylephrine, Agomelatine, Florfenicol, Tildipirosin and so on. Its subsidiary Rivocean Hubei Pharm and Jingshan Ruisheng Pharm are located in Hubei province. Those two subsidiaries both have obtained the ministry of Agriculture veterinary GMP qualification. Another subsidiary Rivocean Jiangsu Pharm has been approved by ISO, EHS and audits from global leading pharmaceutical companies. Attached much importance to R&D, Rivocean owns Provincial Hi-tech R&D center. Being a good partner, Rivocean cooperates with global pharmaceutical companies. Rivocean is dedicated to expanding product portfolio and enhancing competitiveness, with aim to be a leading company which provides healthy products and service around the world. Rivocean is adhering to the enterprise concept of “cherish every drop, form river and ocean", bringing each client, supplier and employee together for long-term and mutual development.

  • Country/Region:
    China
  • On CPHI since:
    2023
  • Certificates:
    1
  • Employees:
    250 - 499
Company types
Manufacturer/Innovator
Veterinary Company
Primary activities
Animal Health
API Producer
Contact info
  • No.23,Jinghe Avenue, Duodao District, Jingmen High-tech zone, Hubei, China
Event information
CPHI & PMEC China 2026
  • 16 Jun 2026 - 18 Jun 2026
  • Shanghai New International Expo Center
  • Visit us at stand W1D36, Pharma Ingredients

Products Featured at CPHI & PMEC China 2026